A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: Results from a randomized controlled multicentre study

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3240-3246

  Lee, Young Ki ^a   Kim, Sung Gyun ^a   Seo, Jang Won ^a   Oh, Ji Eun ^a   Yoon, Jong Woo ^a   Koo, Ja Ryong ^a   Kim, Hyung Jik ^a   Noh, Jung Woo ^a  

^a Hallym University   (South Korea)

Author keywords

Anaemia; Erythropoietin; Haemodialysis

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HEADACHE; HEMODIALYSIS; HUMAN; HYPERTENSION; INJECTION SITE INFLAMMATION; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; TREATMENT DURATION; URINARY TRACT INFECTION;

AGED; ANEMIA; DRUG ADMINISTRATION SCHEDULE; EPOETIN ALFA; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 52449098415     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn255     Document Type: Article

References (17)

1. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990; 300: 573-578
2. Besarab A, Reyes CM, Hornberger J. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients. Am J Kidney Dis 2002; 40: 439-446
3. Kaufman JS, Reda DJ, Fye CL et al. Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N Engl J Med 1998; 339: 578-583
4. Macdougall IC. Once-weekly erythropoietic therapy: is there a difference between the available preparations? Nephrol Dial Transplant 2002; 17: 2047-2051
5. Locatelli F, Canaud B, Giacardy F et al. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). Nephrol Dial Transplant 2003; 18: 362-369
6. Canaud B, Bennhold I, Delons S et al. What is the optimum frequency of administration of r-HuEPO for correcting anemia in hemodialysis patients? Dial Transplant 1995; 24: 286-309
7. Weiss LG, Clyne N, Divino Fihlho J et al. The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Transplant 2000; 15: 2014-2019
8. Locatelli F, Baldamus CA, Villa G et al. Once-weekly compared with three times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study. Am J Kidney Dis 2002; 40: 119-125
9. Tolman C, Richardson D, Bartlett C et al. Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study. J Am Soc Nephrol 2005; 16: 1463-1470
10. Ongkingco JR, Ruley EJ, Turner ME et al. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis. Am J Nephrol 1994; 14: 14-18
11. Lago M, Perez-Garcia R, Garcia de Vinuesa MS et al. Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients. Nephron 1996; 72: 723-724
12. Lui SF, Wong KC, Li PK et al. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patients. Am J Nephrol 1992; 12: 55-60
13. Provenzano R, Garcia-Mayol L, Suchinda P et al. POWER Study Group. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 2004; 61: 392-405
14. Barre P, Reichel H, Suranyi MG et al. Efficacy of once-weekly epoetin alfa. Clin Nephrol 2004; 62: 440-448
15. Macdougall IC, Tucker B, Thompson J et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-1699
16. Korean society of nephrology, registry committee. Renal replacement therapy in Korea Insan memorial dialysis registry 2005. Korean J Nephrol 2007; 26(Suppl 2): S459-S481
17. Beguin Y, Loo M, R'Zik S et al. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. Br J Haematol 1995; 89: 17-23